Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs
Use of class I antiarrhythmic drugs in the elderly is limited by their adverse drug reactions (ADRs), proarrhythmic effect (I A и I C) and high risk of drug interactions. Disopyramide use should be avoided due to its strong anticholinergic properties associated with the risk of cognitive and physica...
Saved in:
Main Authors: | E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1313 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs
by: E. A. Ushkalova, et al.
Published: (2016-11-01) -
Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management
by: V. G. Valiev, et al.
Published: (2005-12-01) -
Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01) -
Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
by: V. L. Doshchitsin, et al.
Published: (2022-07-01) -
Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)